Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AK.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.20NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.221.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.221.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.221.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.221.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.224ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.224ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.224ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.224NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.618ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.618ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.618ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.618NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.458ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.458ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.458ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.458NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.22ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.22NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AG.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AG.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
W.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
W.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
W.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
W.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.264.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.264.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.264.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.264.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used